Rotavirus Infection Alters Splicing of the Stress-Related Transcription Factor XBP1
Overview
Authors
Affiliations
XBP1 is a stress-regulated transcription factor also involved in mammalian host defenses and innate immune response. Our investigation of XBP1 RNA splicing during rotavirus infection revealed that an additional RNA () that corresponded to exon skipping in the pre-RNA is induced depending on the rotavirus strain used. We show that the translation product of (XBP1es) has -activation properties similar to those of XBP1 on ER stress response element (ERSE) containing promoters. Using monoreassortant between ES ("skipping") and ES ("nonskipping") strains of rotavirus, we show that gene 7 encoding the viral translation enhancer NSP3 is involved in this phenomenon and that exon skipping parallels the nuclear relocalization of cytoplasmic PABP. We further show, using recombinant rotaviruses carrying chimeric gene 7, that the ES phenotype is linked to the eIF4G-binding domain of NSP3. Because the XBP1 transcription factor is involved in stress and immunological responses, our results suggest an alternative way to activate XBP1 upon viral infection or nuclear localization of PABP. Rotavirus is one of the most important pathogens causing severe gastroenteritis in young children worldwide. Here we show that infection with several rotavirus strains induces an alternative splicing of the RNA encoding the stressed-induced transcription factor XBP1. The genetic determinant of XBP1 splicing is the viral RNA translation enhancer NSP3. Since XBP1 is involved in cellular stress and immune responses and since the XBP1 protein made from the alternatively spliced RNA is an active transcription factor, our observations raise the question of whether alternative splicing is a cellular response to rotavirus infection.
XBP1 is required in Th2 polarization induction in airway allergy.
Zeng X, Xiao X, Hu S, He W, Wu G, Geng X Theranostics. 2022; 12(12):5337-5349.
PMID: 35910793 PMC: 9330522. DOI: 10.7150/thno.75100.
When Poly(A) Binding Proteins Meet Viral Infections, Including SARS-CoV-2.
Gao J, Tang Y, Hu W, Zheng C J Virol. 2022; 96(7):e0013622.
PMID: 35293770 PMC: 9006897. DOI: 10.1128/jvi.00136-22.
Cui M, Zhao Q, Wang J, Si Y, Cheng S, Ding W J Virol. 2021; 96(3):e0110321.
PMID: 34851146 PMC: 8826799. DOI: 10.1128/JVI.01103-21.
Kachaev Z, Ivashchenko S, Kozlov E, Lebedeva L, Shidlovskii Y Cells. 2021; 10(11).
PMID: 34831461 PMC: 8623629. DOI: 10.3390/cells10113239.
Patra U, Mukhopadhyay U, Mukherjee A, Dutta S, Chawla-Sarkar M Virulence. 2021; 12(1):1022-1062.
PMID: 33818275 PMC: 8023246. DOI: 10.1080/21505594.2021.1903198.